Home / Import refusals / 1FX-0333205-3/10002/1

FDA Import Refusal 1FX-0333205-3/10002/1 — Glaxosmithkline

Glaxosmithkline — FEI 3009635165

The FDA refused shipment 1FX-0333205-3/10002/1 from Glaxosmithkline (Colombia) on June 12, 2026. The refused product falls under Drugs and Biologics — ACETAMINOPHEN (ANALGESIC). Cited charge: 75 This firm has 5 or more other import refusals on record.

Refusal Details

Date
June 12, 2026
Country
Colombia
Product Category
Drugs and Biologics
Product Code
60LAA01 ACETAMINOPHEN (ANALGESIC)
Charges
75

Other import refusals

  • 1FX-9324952-1/30002/1 (Tue Jun 02 2026 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • NUV-3881703-0/70002/1 (Tue Feb 24 2026 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • AEK-9318923-9/110002/1 (Thu Feb 19 2026 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • AEK-9449370-5/10003/1 (Fri Feb 06 2026 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • 799-1894214-1/10003/1 (Wed Feb 04 2026 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)

FDA data resources